{"id":2784,"date":"2019-10-08T00:51:33","date_gmt":"2019-10-07T22:51:33","guid":{"rendered":"https:\/\/idibell.cat\/?page_id=2784"},"modified":"2024-03-12T14:38:43","modified_gmt":"2024-03-12T13:38:43","slug":"grupo-de-investigacion-en-enfermedades-cardiovasculares-bio-heart","status":"publish","type":"page","link":"https:\/\/idibell.cat\/es\/investigacion\/area-de-medicina-traslacional\/programa-de-enfermedades-cardiovasculares-respiratorias-sistemicas-y-de-envejecimiento-celular\/grupo-de-investigacion-en-enfermedades-cardiovasculares-bio-heart\/","title":{"rendered":"Grupo de Investigaci\u00f3n en Enfermedades Cardiovasculares (BIO-HEART)"},"content":{"rendered":"\n
Solomon SD, McMurray JJV, Claggett B, de Boer RA, DeMets D, Hernandez AF, Inzucchi SE, Kosiborod MN, Lam CSP, Martinez F, Shah SJ, Desai AS, Jhund PS, Belohlavek J, Chiang CE, Borleffs CJW, Comin Colet J, Dobreanu D, Drozdz J, Fang JC, Alcocer Gamba MA, Al Habeeb W, Han Y, Cabrera Honorio JW, Janssens SP, Katova T, Kitakaze M, Merkely B, O’Meara E, Saraiva JFK, Tereshchenko SN, Thierer J, Vaduganathan M, Vardeny O, Verma S, Pham VN, Wilder\u00e4ng U, Zaozerska N, Bachus E, Lindholm D, Petersson M, Langkilde AM, DELIVER Trial Committees and I. Dapagliflozin in Heart Failure with Mildly Reduced or Preserved Ejection Fraction<\/strong>. N. Engl. J. Med. 2022;387(12):1089-1098. doi:10.1056\/NEJMoa2206286.<\/p>\n Senage T, Paul A, Le Tourneau T, Fellah Hebia I, Vadori M, Bashir S, Galinanes M, Bottio T, Gerosa G, Evangelista A, Badano LP, Nassi A, Costa C, Cesare G, Manji RA, de Monchy CC, Piriou N, Capoulade R, Serfaty JM, Guimbretiere G, Dantan E, Ruiz Majoral A, du Fou GC, Ben Arye SL, Govani L, Yehuda S, Abramovitch SB, Amon R, Reuven EM, Atiya Nasagi Y, Yu H, Iop L, Casos K, Kuguel SG, Blasco Lucas A, Permanyer E, Sbraga F, Llatjos R, Moreno Gonzalez G, Sanchez Martinez M, Breimer ME, Holgersson J, Teneberg S, Pascual Gilabert M, Nonell Canals A, Takeuchi Y, Chen X, Manez R, Roussel JC, Soulillou JP, Cozzi E, Padler Karavani V. The role of antibody responses against glycans in bioprosthetic heart valve calcification and deterioration<\/strong>. Nat. Med. 2022;28(2):283-294. doi:10.1038\/s41591-022-01682-w.<\/p>\n Voors AA, Angermann CE, Teerlink JR, Collins SP, Kosiborod M, Biegus J, Ferreira JP, Nassif ME, Psotka MA, Tromp J, Borleffs CJW, Ma C, Comin Colet J, Fu M, Janssens SP, Kiss RG, Mentz RJ, Sakata Y, Schirmer H, Schou M, Schulze PC, Spinarova L, Volterrani M, Wranicz JK, Zeymer U, Zieroth S, Brueckmann M, Blatchford JP, Salsali A, Ponikowski P. The SGLT2 inhibitor empagliflozin in patients hospitalized for acute heart failure: a multinational randomized trial<\/strong>. Nat. Med. 2022;28(3):568-574. doi:10.1038\/s41591-021-01659-1.<\/p>\n Moliner P, Comin Colet J. Iron deficiency and supplementation therapy in heart failure<\/strong>. Nat. Rev. Cardiol. 2022;19(9):571-572. doi:10.1038\/s41569-022-00747-0.<\/p>\n Kosiborod MN, Angermann CE, Collins SP, Teerlink JR, Ponikowski P, Biegus J, Comin Colet J, Ferreira JP, Mentz RJ, Nassif ME, Psotka MA, Tromp J, Brueckmann M, Blatchford JP, Salsali A, Voors AA. Effects of Empagliflozin on Symptoms, Physical Limitations and Quality of Life in Patients Hospitalized for Acute Heart Failure – Results From the EMPULSE Trial<\/strong>. Circulation. 2022;146(4):279-288. doi:10.1161\/CIRCULATIONAHA.122.059725.<\/p>\n\t\t\t\t\tProyectos seleccionados<\/a>\n\t\t\t\t\t\t\t\t\t\t\tExpand<\/i><\/a>\n\t\t\t\t\t MCI21056. Estrategias preventivas integradoras para el c\u00e1ncer y las enfermedades cardiovasculares basadas en inteligencia artificial (IA ) Ministerio de Ciencia e Innovaci\u00f3n<\/strong>. Budget: 569250. 2022-2024. PI: Com\u00edn Colet, Josep.<\/p>\n MCI21056. TED 2021- CCSHARED – Artificial intelligence (AI) driven integrative preventive strategies for cancer and CV disease (ARTICCA)<\/strong>. Ministerio de Ciencia e Innovaci\u00f3n. Budget: 569250. 2022-2024. PI: Josep Comin.\u00bb<\/p>\n 18ACL013. Estudio Onyx ONE; un estudio aleatorizado y controlado con el stent Resolute Onyx y tratamiento de doble antiagregaci\u00f3n plaquetaria [DAPT] de Un mes para pacientes con alto riesgo de sangrado<\/strong>. Budget: 350800. 2018- . PI: Cequier Fillat, \u00c1ngel.<\/p>\n 20ACL119. HELIOS-B: ESTUDIO DE FASE 3, ALEATORIZADO, DOBLE CIEGO, CONTROLADO CON PLACEBO Y MULTIC\u00c9NTRICO PARA EVALUAR LA EFICACIA Y LA SEGURIDAD DE VUTRISIR\u00c1N EN PACIENTES CON AMILOIDOSIS CARDIACA POR TRANSTIRETINA (AMILOIDOSIS POR ATTR CON MIOCARDIOPAT\u00cdA)<\/strong>. Budget: 299745. 2020- . PI: Gonz\u00e1lez Costello, Jos\u00e9.<\/p>\n MCI22001. Clinical trial to evaluate the administration of ApTOLL in Acute Myocardial Infarction. APSTEMI. Ministerio de Ciencia e Innovaci\u00f3n<\/strong>. Budget: 259100,89. 2022-2025. PI: G\u00f3mez Hospital, Joan Antoni.<\/p>\n\t\t\t\t\n Grupo de Investigaci\u00f3n en Enfermedades Cardiovasculares (BIO-HEART) Resumen Este grupo, focalizado en la investigaci\u00f3n cl\u00ednica de las enfermedades y riesgo cardiovasculares, presenta una amplia experiencia en un campo de gran relevancia, ya que las enfermedades cardiovasculares contin\u00faan siendo la mayor causa de mortalidad en el mundo occidental tanto en mujeres como en hombres. El grupo […]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":568,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"site-sidebar-layout":"no-sidebar","site-content-layout":"page-builder","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"disabled","ast-breadcrumbs-content":"","ast-featured-img":"disabled","footer-sml-layout":"","theme-transparent-header-meta":"default","adv-header-id-meta":"","stick-header-meta":"default","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""}},"footnotes":""},"publishpress_future_action":{"enabled":false,"date":"2024-05-05 00:17:13","action":"change-status","newStatus":"draft","terms":[],"taxonomy":""},"_links":{"self":[{"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/pages\/2784"}],"collection":[{"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/comments?post=2784"}],"version-history":[{"count":6,"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/pages\/2784\/revisions"}],"predecessor-version":[{"id":24007,"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/pages\/2784\/revisions\/24007"}],"up":[{"embeddable":true,"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/pages\/568"}],"wp:attachment":[{"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/media?parent=2784"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}\n\t\tComin Colet, Josep \n\t<\/h4>\n
\n\t\t\n\t\tjcomin@idibell.cat\n\t\t<\/a>\n\t<\/h4>\n
\n\t\tInvestigadores principales\n\t<\/h2>\n\t\t\t\t\n
\n\t\tComin Colet, Josep \n\t<\/h4>\n
\n\t\t\n\t\tjcomin@idibell.cat\n\t\t<\/a>\n\t<\/h4>\n\t\t\t\t\n
\n\t\tGomez Lara, Josep\n\t<\/h4>\n
\n\t\t\n\t\tjgomezl@idibell.cat\n\t\t<\/a>\n\t<\/h4>\n\t\t\t\t\n
\n\t\tAriza Sole, Albert\n\t<\/h4>\n
\n\t\t\n\t\taariza@idibell.cat\n\t\t<\/a>\n\t<\/h4>\n\t\t\t\t\n
\n\t\tEnjuanes Grau, Cristina\n\t<\/h4>\n
\n\t\t\n\t\tcenjuanes@idibell.cat\n\t\t<\/a>\n\t<\/h4>\n\t\t\t\t\n
\n\t\tGonzalez Costello, Jos\u00e9\n\t<\/h4>\n
\n\t\t\n\t\tjgcostello@idibell.cat\n\t\t<\/a>\n\t<\/h4>\n\t\t\t\t\n
\n\t\tTajes Ordu\u00f1a, Marta\n\t<\/h4>\n
\n\t\t\n\t\tmtajes@idibell.cat\n\t\t<\/a>\n\t<\/h4>\n\t\t\t\t\n
\n\t\tFerreiro Gutierrez, Jose Luis\n\t<\/h4>\n
\n\t\t\n\t\tjferreiro@idibell.cat\n\t\t<\/a>\n\t<\/h4>\n\t\t\t\t\n
\n\t\tIborra Ortega, Elena\n\t<\/h4>\n
\n\t\t\n\t\teiborra@idibell.cat\n\t\t<\/a>\n\t<\/h4>\n
\n\t\tENLACES RELACIONADOS\n\t<\/h4>\n
\n\t\t\n\t\t@JosepComin\n\t\t<\/a>\n\t<\/h4>\n
\n\t\t\n\t\t@AlbertAriza3\n\t\t<\/a>\n\t<\/h4>\n
\n\t\t\n\t\t@DrJLFerreiro\n\t\t<\/a>\n\t<\/h4>\n
\n\t\tEquipo\n\t<\/h2>\n\t\t\t\t\t\t\t\t\t\t\t\tJefes\/as de grupo\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t\t\t\t\tInvestigadores\/as principales\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t\t\t\t\tInvestigadores\/as cl\u00ednicos\/cas\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t\t\t\t\tInvestigadores\/as postdoctorales\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t\t\t\t\tInvestigadores\/as predoctorales\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t\t\t\t\tSoporte cient\u00edfico\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t\t\t\t\tSoporte de gesti\u00f3n\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t\t\t\t\tEstudiantes\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t\t\t\t\tColaboradores\/as\t\t\t\t<\/a>\n\t\t\t\t\t\tJefes\/as de grupo\n\t\t\t\t\t\t\t\t\t\t\t
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n\t\tNoticias relacionadas\n\t<\/h2>\n\t\t\n\t\t\t\t<\/a>\n\t\t\tCuatro grupos de investigaci\u00f3n del IDIBELL reciben financiaci\u00f3n de La Marat\u00f3 de 3Cat dedicada a las enfermedades cardiovasculares<\/a>\n\t\t\tBy comunicacio<\/a>\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t | \n\t\t\t\t\t\t\t\t\t09\/11\/2023\t\t\t\t\t\t\t\n\t\t\n\t\t\t\t<\/a>\n\t\t\tEl Programa de Insuficiencia Card\u00edaca Comunitaria de la GTMS logra reducir las hospitalizaciones y las muertes a los 90 y a los 180 d\u00edas del alta<\/a>\n\t\t\tBy comunicacio<\/a>\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t | \n\t\t\t\t\t\t\t\t\t29\/08\/2023\t\t\t\t\t\t\t\n\t\t\n\t\t\t\t<\/a>\n\t\t\tUn estudio concluye que la atenci\u00f3n integrada territorial de las personas con insuficiencia card\u00edaca reduce el impacto de la desigualdad socioecon\u00f3mica<\/a>\n\t\t\tBy comunicacio<\/a>\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t | \n\t\t\t\t\t\t\t\t\t24\/08\/2023\t\t\t\t\t\t\t\n\t\t\n\t\t\t\t<\/a>\n\t\t\tUn nuevo estudio busca soluciones para minimizar las complicaciones en los trasplantes card\u00edacos<\/a>\n\t\t\tBy comunicacio<\/a>\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t | \n\t\t\t\t\t\t\t\t\t12\/06\/2023\t\t\t\t\t\t\t\n\t\t\n\t\t\t\t<\/a>\n\t\t\tLa investigaci\u00f3n en mHealth de Bellvitge, destacada en el congreso m\u00e1s relevante en el \u00e1mbito mundial de Insuficiencia Card\u00edaca<\/a>\n\t\t\tBy comunicacio<\/a>\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t | \n\t\t\t\t\t\t\t\t\t26\/05\/2023\t\t\t\t\t\t\t\n\t\t\n\t\t\t\t<\/a>\n\t\t\tEl Hospital de Bellvitge y el IDIBELL lideran un ensayo cl\u00ednico estatal para reducir el impacto de las infecciones en los pacientes trasplantados de coraz\u00f3n<\/a>\n\t\t\tBy comunicacio<\/a>\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t | \n\t\t\t\t\t\t\t\t\t31\/03\/2023\t\t\t\t\t\t\t\n\t\t\n\t\t\t\t<\/a>\n\t\t\tEl Hospital de Bellvitge, IDIBELL y Astrazeneca prueban una aplicaci\u00f3n que monitoriza la insuficiencia card\u00edaca mediante la voz<\/a>\n\t\t\tBy comunicacio<\/a>\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t | \n\t\t\t\t\t\t\t\t\t06\/03\/2023\t\t\t\t\t\t\t\n\t\t\n\t\t\t\t<\/a>\n\t\t\tUn grupo de excelencia integrado por investigadores del IDIBELL y profesionales de Cardiolog\u00eda del HUB se integra en el CIBER de Enfermedades Cardiovasculares<\/a>\n\t\t\tBy comunicacio<\/a>\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t | \n\t\t\t\t\t\t\t\t\t03\/02\/2023\t\t\t\t\t\t\t\n\t\t\n\t\t\t\t<\/a>\n\t\t\tEl Dr. Josep Com\u00edn, coautor de sendas publicaciones en Nature Medicine y JACC sobre un nuevo f\u00e1rmaco contra la insuficiencia card\u00edaca<\/a>\n\t\t\tBy comunicacio<\/a>\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t | \n\t\t\t\t\t\t\t\t\t30\/01\/2023\t\t\t\t\t\t\t\n\t\t\n\t\t\t\t<\/a>\n\t\t\tIDIBELL recibe 1,2 millones de euros en ayudas para impulsar la investigaci\u00f3n cient\u00edfica y su transferencia<\/a>\n\t\t\tBy comunicacio<\/a>\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t | \n\t\t\t\t\t\t\t\t\t10\/01\/2023\t\t\t\t\t\t\t\n\t\t\n\n","protected":false},"excerpt":{"rendered":"